The average one-year price target for Clover Health Investments (NasdaqGS:CLOV) has been revised to $2.92 / share. This is a ...

Clover Health Investments is now a contrarian buy, with the market underestimating its path to profitability in 2026. See why I rate the CLOV stock a Buy.

Over the last six months, Clover Health’s shares have sunk to $2.60, producing a disappointing 13.5% loss - a stark contrast ...

Clover Health Investments is trading lower Tuesday afternoon after the Trump administration proposed flat MA payment rates for 2027.

Clover Health also announced a significant increase in its Medicare Advantage membership. The membership rose to 153,000, marking a 53% increase during the Annual Enrollment Period. The company ...

Shares of Clover Health (CLOV) plunged ~20% on Wednesday following the company’s Q3 2025 results, as the health insurer sharply lowered its full-year guidance for adjusted EBITDA despite increasing ...

Detailed price information for Clover Health Investments Corp (CLOV-Q) from The Globe and Mail including charting and trades.

Clover Health Investments, Corp. (CLOV) closed the most recent trading day at $4.09, moving -0.24% from the previous trading session. This change lagged the S&P 500's daily gain of 1.02%. Meanwhile, ...

Investors can certainly boost their returns by concentrating on stocks trading between $1 and $10. However, a disciplined ...

Clover Health Investments Corp. Cl A stock grades by Barron's. View CLOV fundamental and sentiment analysis powered by MarketGrader.